NCT02694302.

Trial name or title	Clinical trial of robot‐assisted‐gait‐training (RAGT) in stroke patients (Walkbot)
Methods	Randomised 2 arms
Participants	Inclusion criteria Age older than 19 years and younger than 80 years Weight under 100 kg Height less than 200 cm Able to walk independently before onset of stroke Ischaemic or haemorrhagic stroke patients Motor paralysis and gait disturbance after stroke and seeking rehabilitation treatment FAC under 3 (0 ˜ 2) Subacute stroke patients, i.e. after 3 days and before 3 months of stroke onset Be informed of the nature of the study and agreed on written consent voluntarily Taking medications or scheduled medications due to stroke Exclusion criteria Contraindications to weight bearing such as fractures, etc. Uncontrolled stage 2 hypertension (systolic over 160 mm Hg or diastolic over 100 mm Hg) or with uncontrolled orthostatic hypotension Cardiopulmonary disease or other underlying diseases that cannot tolerate gait training Severe skin damage and bedsore on wearing part of the trial device Pregnant or breastfeeding Participationin other clinical trials within 30 days People whom the investigator considers inappropriate to participate in the study
Interventions	Walkbot (robot‐assisted gait training) 30 minutes and conventional physical therapy 30 minutes per day to be administered 5 times a week for 3 weeks Conventional physical therapy 30 minutes to be administered twice a day, 5 times a week for 3 weeks
Outcomes	Primary outcome measure FAC Secondary outcome measures Motricity Index 10‐metre walk test 6‐minute walk test Medical Research Council Modified Ashworth Scale Fugl‐Meyer Assessment Modified Barthel Index National Institutes of Health Stroke Scale Beck Depression Inventory Treatment Satisfaction Survey
Starting date	March 2014
Contact information	P&S Mechanics Co., Ltd.
Notes